 Drug response electropharmacologic study patients ventricular tachyarrhythmias importance ventricular refractoriness clinical electrophysiologic predictors successful antiarrhythmic drug therapy patients inducible ventricular tachycardia consecutive patients serial electropharmacologic trials Structural heart disease present patients effective therapy presence coronary artery disease history prior myocardial infarction present patients antiarrhythmic drug therapy corrected QT interval ventricular effective refractory period pacing cycle length ms responders nonresponders QT versus ms ventricular effective refractory period versus ms addition interelectrogram interval ventricular extrastimulus ventricular tachycardia responders nonresponders versus ms Logistic regression analysis short ventricular interelectrogram interval absence prior myocardial infarction independent predictors antiarrhythmic drug suppression induction ventricular tachycardia Greater drug-induced increments ventricular effective functional refractory periods responders nonresponders ventricular interelectrogram interval baseline electrophysiologic measurements patients inducible ventricular tachycardia likely antiarrhythmic drug therapy patients drug-induced electrophysiologic changes